16/03/2017 16:14:31

Travis Perkins PLC : Director/PDMR Shareholding

Related content
02 Jan - 
Travis Perkins PLC : Director/PDMR Shareholding
02 Jan - 
Travis Perkins PLC : Director/PDMR Shareholding
02 Jan - 
Travis Perkins PLC : Total voting rights

The Company announces that, on 15 March 2017, the following awards in respect of ordinary shares of 10p each in the Company ("shares") were made by way of nil cost option under the Deferred Share Bonus Plan to the PDMRs as set out below. The number of shares subject to the options awarded has been calculated using the average market price over the dealing days falling within the last 30 days of the Company's 2016 financial year of £14.284.

Name Status Number

of Options

John Carter Director 10,117*
Tony Buffin Director 6,354*
Norman Bell PDMR 3,828
Carol Kavanagh PDMR 3,391
Martin Meech PDMR 3,653
Paul Tallentire PDMR 3,509
Frank Elkins PDMR 3,180
Andrew Harrison PDMR 3,256
Deborah Grimason PDMR 1,256
Neil Pearce PDMR 567

The options over these shares will normally be exercisable from 15 March 2020.

 *These awards are conditional on the approval of the directors' remuneration policy by shareholders at the 2017 Annual General Meeting.

The Company also announces that, on 15 March 2017, the following awards in respect of ordinary shares of 10p each in the Company ("shares") were made by way of nil cost option under the Travis Perkins Performance Share Plan to the PDMRs as set out below.  The number of shares subject to the options awarded has been calculated using the average market price over the 5 dealing days prior to the award of £14.88.

Name Status Number

of Options

John Carter Director 69,569*
Tony Buffin Director 53,758*
Alan Williams Director 50,403*
Norman Bell PDMR 29,514
Carol Kavanagh PDMR 26,141
Martin Meech PDMR 27,827
Paul Tallentire PDMR 28,225
Frank Elkins PDMR 28,225
Andrew Harrison PDMR 29,193
Deborah Grimason PDMR 17,774
Cheryl Millington PDMR 27,419
Neil Pearce PDMR 10,080

A proportion of some of these options over these shares may include an Approved Option Award.  Approved options include a Linked Award to fund the option cost of the Approved option. Options will normally be exercisable from 15 March 2020, subject to the satisfaction on performance conditions.

*These awards are subject to an additional 12 month holding period following vesting.

For further information please contact:

Helen O'Keefe

Deputy Company Secretary

+44 (0)1604 685910


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Travis Perkins PLC via Globenewswire

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Man Group PLC : Form 8.3 - [Intu Properties plc] - Amendment

23/01/2018 14:37:27
Amendment to cash-settled derivatives (50p ordinary) positions, section 2(a). FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: ..

Alliance Trust PLC : Net Asset Value(s)

23/01/2018 13:47:03
ALLIANCE TRUST PLC                                    At the close of business on Monday 22 January 2018: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 814.7p -       including income, 818.7p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding inco..

Investec Bank plc : Form 8.5 (EPT/RI) - Melrose Industries plc

23/01/2018 10:51:00
 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY 1.         KEY INFORMATION (a) Name of exempt principal trader:   Investec Bank plc   (b) Name of offeror/offeree in relation to whose relevant ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Portola Pharmaceuticals Announces Acceptance of Late-Breaker Abstract Highlighting New Data for Andexanet Alfa at ACC.18
2
Simmons Reports Fourth Quarter 2017 Earnings
3
Southern Missouri Bancorp Reports Preliminary Results for Second Quarter of Fiscal 2018; Dividend of $0.11 Per Common Share Declared; Conference Call to Discuss Results Scheduled for Tuesday, January 23 at 3:30 P.m. Central Time
4
Microdrones and ASPRS to host Workshop Day, February 8th, in conjunction with the ILMF and ASPRS Conference in Denver, Colorado
5
Histogenics Corporation Announces Pricing of Underwritten Registered Direct Offering of 2,340,430 Shares of Common Stock

Related stock quotes

Travis Perkins PLC ORD 1.. 1,470.00 -0.7% Stock price decreasing

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 January 2018 19:33:11
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180122.2 - EUROWEB6 - 2018-01-23 20:33:11 - 2018-01-23 19:33:11 - 1000 - Website: OKAY